NFKB1 and Stroke: Together, these findings indicate that early administration of a NF-κB inhibitor (the first injection of MEDS-23 was four hours after the induction of stroke) and its subsequent continuation is capable of mitigating the severity of neurological deficits in post-stroke rats.